{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:20:59Z","timestamp":1787642459317,"version":"build-2736575974"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002475","name":"Duksung Women`s University","doi-asserted-by":"publisher","award":["No. 3000010844"],"award-info":[{"award-number":["No. 3000010844"]}],"id":[{"id":"10.13039\/501100002475","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lab Anim Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Preclinical (in vivo) experiments for efficacy and toxicity are predominantly conducted in mice. Nevertheless, human-derived cells, tissues, and organoids are generally rejected by the immune system of mice. Thus, immunodeficient mice are used as xenograft models to overcome immune rejection in cancer research. Xenograft mouse models are divided into ectopic, orthotopic, and metastatic models based on the transplant sites. Xenograft mouse models are established by transplanting cancer cells, tissues, or organoids derived from patients. These models show diverse success rates and production times depending on the transplant materials and recipient mice. In this review, mouse strains for the establishment of xenograft models in cancer research are introduced. Genetic engineering of immune cells, such as T cells, B cells, and natural killer cells, shows specific properties. To select an immunodeficient mouse strain, the differences in the characteristics of the models must be understood. Optimized mouse models can provide information to investigate cancer progression and evaluate anticancer drugs.<\/jats:p>","DOI":"10.1186\/s42826-026-00292-8","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:42:57Z","timestamp":1787640177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Considerations for selecting immunodeficient mouse strains for cancer xenograft models"],"prefix":"10.1186","volume":"42","author":[{"given":"Jiwon","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9124-9052","authenticated-orcid":false,"given":"Joohee","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"issue":"3","key":"292_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"292_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s43856-023-00304-x","volume":"3","author":"NL Hudock","year":"2023","unstructured":"Hudock NL, Mani K, Khunsriraksakul C, Walter V, Nekhlyudov L, Wang M, et al. Future trends in incidence and long-term survival of metastatic cancer in the United States. Commun Med (Lond). 2023;3(1):76. https:\/\/doi.org\/10.1038\/s43856-023-00304-x.","journal-title":"Commun Med (Lond)"},{"key":"292_CR3","doi-asserted-by":"publisher","first-page":"117242","DOI":"10.1016\/j.lfs.2019.117242","volume":"242","author":"S Wang","year":"2020","unstructured":"Wang S, Lai X, Deng Y, Song Y. Correlation between mouse age and human age in anti-tumor research: Significance and method establishment. Life Sci. 2020;242:117242. https:\/\/doi.org\/10.1016\/j.lfs.2019.117242.","journal-title":"Life Sci"},{"issue":"4","key":"292_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1242\/dmm.028274","volume":"10","author":"I Holen","year":"2017","unstructured":"Holen I, Speirs V, Morrissey B, Blyth K. In vivo models in breast cancer research: progress, challenges and future directions. Dis Model Mech. 2017;10(4):359\u201371. https:\/\/doi.org\/10.1242\/dmm.028274.","journal-title":"Dis Model Mech"},{"key":"292_CR5","doi-asserted-by":"publisher","first-page":"1007579","DOI":"10.3389\/fimmu.2022.1007579","volume":"13","author":"J Chen","year":"2022","unstructured":"Chen J, Liao S, Xiao Z, Pan Q, Wang X, Shen K, et al. The development and improvement of immunodeficient mice and humanized immune system mouse models. Front Immunol. 2022;13:1007579. https:\/\/doi.org\/10.3389\/fimmu.2022.1007579.","journal-title":"Front Immunol"},{"issue":"2","key":"292_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jhep.2019.09.028","volume":"72","author":"E Bresnahan","year":"2020","unstructured":"Bresnahan E, Ramadori P, Heikenwalder M, Zender L, Lujambio A. Novel patient-derived preclinical models of liver cancer. J Hepatol. 2020;72(2):239\u201349. https:\/\/doi.org\/10.1016\/j.jhep.2019.09.028.","journal-title":"J Hepatol"},{"issue":"3","key":"292_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41571-022-00721-2","volume":"20","author":"J Chuprin","year":"2023","unstructured":"Chuprin J, Buettner H, Seedhom MO, Greiner DL, Keck JG, Ishikawa F, et al. Humanized mouse models for immuno-oncology research. Nat Rev Clin Oncol. 2023;20(3):192\u2013206. https:\/\/doi.org\/10.1038\/s41571-022-00721-2.","journal-title":"Nat Rev Clin Oncol"},{"key":"292_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev-cancerbio-050520-100526","volume":"5","author":"S Guil-Luna","year":"2021","unstructured":"Guil-Luna S, Sedlik C, Piaggio E. Humanized mouse models to evaluate cancer immunotherapeutics. Annu Rev Cancer Biol. 2021;5:119\u201336. https:\/\/doi.org\/10.1146\/annurev-cancerbio-050520-100526.","journal-title":"Annu Rev Cancer Biol"},{"issue":"8","key":"292_CR9","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.7150\/ijbs.5033","volume":"8","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Burnley P, Coder B, Su D-M. Insights on FoxN1 biological significance and usages of the nude mouse in studies of T-lymphopoiesis. Int J Biol Sci. 2012;8(8):1156\u201367. https:\/\/doi.org\/10.7150\/ijbs.5033.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"292_CR10","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/cmi.2012.2","volume":"9","author":"R Ito","year":"2012","unstructured":"Ito R, Takahashi T, Katano I, Ito M. Current advances in humanized mouse models. Cell Mol Immunol. 2012;9(3):208\u201314. https:\/\/doi.org\/10.1038\/cmi.2012.2.","journal-title":"Cell Mol Immunol"},{"issue":"7718","key":"292_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41586-018-0409-3","volume":"560","author":"U Ben-David","year":"2018","unstructured":"Ben-David U, Siranosian B, Ha G, Tang H, Oren Y, Hinohara K, et al. Genetic and transcriptional evolution alters cancer cell line drug response. Nature. 2018;560(7718):325\u201330. https:\/\/doi.org\/10.1038\/s41586-018-0409-3.","journal-title":"Nature"},{"issue":"4","key":"292_CR12","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/j.1699-0463.1969.tb04520.x","volume":"77","author":"J Rygaard","year":"1969","unstructured":"Rygaard J, Povlsen CO. Heterotransplantation of a human malignant tumour to Nude mice. Acta Pathol Microbiol Scand. 1969;77(4):758\u201360. https:\/\/doi.org\/10.1111\/j.1699-0463.1969.tb04520.x.","journal-title":"Acta Pathol Microbiol Scand"},{"issue":"1","key":"292_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5487\/TR.2014.30.1.001","volume":"30","author":"J Jung","year":"2014","unstructured":"Jung J. Human tumor xenograft models for preclinical assessment of anticancer drug development. Toxicol Res. 2014;30(1):1\u20135. https:\/\/doi.org\/10.5487\/TR.2014.30.1.001.","journal-title":"Toxicol Res"},{"key":"292_CR14","doi-asserted-by":"publisher","unstructured":"Kwon J, Oh S, Park M, Kong JS, Lee S, Lee H, et al. Advanced xenograft model with cotransplantation of patient-derived organoids and endothelial colony-forming cells for precision medicine. J Oncol. 2021;99945355. https:\/\/doi.org\/10.1155\/2012\/9994535.","DOI":"10.1155\/2012\/9994535"},{"issue":"1","key":"292_CR15","doi-asserted-by":"publisher","first-page":"23531","DOI":"10.1038\/s41598-024-75493-z","volume":"14","author":"HJ Kwon","year":"2024","unstructured":"Kwon HJ, Park JW, Chung HK, Jung J. Comprehensive model for simultaneous monitoring of primary tumor to metastatic cancer utilizing Prkdc and Il2rg double knockout mice. Sci Rep. 2024;14(1):23531. https:\/\/doi.org\/10.1038\/s41598-024-75493-z.","journal-title":"Sci Rep"},{"issue":"3","key":"292_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1017\/s0016672300010168","volume":"8","author":"SP Flanagan","year":"1966","unstructured":"Flanagan SP. Nude\u2019, a new hairless gene with pleiotropic effects in the mouse. Genet Res. 1966;8(3):295\u2013309. https:\/\/doi.org\/10.1017\/s0016672300010168.","journal-title":"Genet Res"},{"issue":"5126","key":"292_CR17","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/217370a0","volume":"217","author":"EM Pantelouris","year":"1968","unstructured":"Pantelouris EM. Absence of thymus in a mouse mutant. Nature. 1968;217(5126):370\u201371. https:\/\/doi.org\/10.1038\/217370a0.","journal-title":"Nature"},{"key":"292_CR18","doi-asserted-by":"publisher","unstructured":"Hirenallur-Shanthappa DK, Ramirez JA, Iritani BM. Chapter 5. Immunodeficient mice: The backbone of patient-derived tumor xenograft models. Patient derived tumor xenograft models, Promise, potential and practice. Acad press. 2017;57\u201373. https:\/\/doi.org\/10.1016\/B978-0-12-804010-2.00005-9.","DOI":"10.1016\/B978-0-12-804010-2.00005-9"},{"issue":"6","key":"292_CR19","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3803\/EnM.2022.1636","volume":"37","author":"MJ Jeon","year":"2022","unstructured":"Jeon MJ, Haugen BR. Preclinical models of follicular cell-derived thyroid cancer: an overview from cancer cell lines to mouse models. Endocrinol Metab (Seoul). 2022;37(6):830\u201338. https:\/\/doi.org\/10.3803\/EnM.2022.1636.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"1","key":"292_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1354\/vp.44-1-1","volume":"44","author":"K Knostman","year":"2007","unstructured":"Knostman K, Jhiang S, Capen CC. Genetic alterations in thyroid cancer: the role of mouse models. Vet Pathol. 2007;44(1):1\u201314. https:\/\/doi.org\/10.1354\/vp.44-1-1.","journal-title":"Vet Pathol"},{"key":"292_CR21","doi-asserted-by":"publisher","unstructured":"Bosma MJ, Philips RA, Schuler Walter. The Scid mouse: characterization and potential uses. Curr Top Microbiol Immunol. Volume XII. Springer Berlin, Heidelbrga. 2011. p. 263. https:\/\/doi.org\/10.1007\/978-3-642-74974-2.","DOI":"10.1007\/978-3-642-74974-2"},{"key":"292_CR22","unstructured":"Pla M, Mahouy G. The SCID mouse. Nouv Rev Fr Hematol (1978). 1991; 33(6):489\u2009\u2013\u200991."},{"issue":"7","key":"292_CR23","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S1471-4906(01)01943-3","volume":"22","author":"RB Bankert","year":"2001","unstructured":"Bankert RB, Egilmez NK, Hess SD. Human\u2013SCID mouse chimeric models for the evaluation of anti-cancer therapies. Trends Immunol. 2001;22(7):386\u201393. https:\/\/doi.org\/10.1016\/S1471-4906(01)01943-3. doi.:.","journal-title":"Trends Immunol"},{"key":"292_CR24","doi-asserted-by":"publisher","unstructured":"Pastoret PP, Griebel P, Bazin H, Govaerts A. XVII- the SCID mouse mutant: definition and potential use as a model for immune disorders. In: Handbook of Vertebrate Immunology. Academic. 1998. pp. 603\u201318. https:\/\/doi.org\/10.1016\/B978-012546401-7\/50019-6.","DOI":"10.1016\/B978-012546401-7\/50019-6"},{"key":"292_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev.iy.09.040191.001543","volume":"9","author":"MJ Bosma","year":"1991","unstructured":"Bosma MJ, Carrol AM. The SCID mouse mutant: definition, characterization, and potential uses. Annu Rev Immunol. 1991;9:323\u201350. https:\/\/doi.org\/10.1146\/annurev.iy.09.040191.001543.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"292_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1538\/expanim1978.29.1_1","volume":"29","author":"S Makino","year":"1980","unstructured":"Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu. 1980;29(1):1\u201313. https:\/\/doi.org\/10.1538\/expanim1978.29.1_1.","journal-title":"Jikken Dobutsu"},{"issue":"8","key":"292_CR27","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1182\/blood-2012-06-440354","volume":"121","author":"T Yamauchi","year":"2013","unstructured":"Yamauchi T, Takenaka K, Urata S, Shima T, Kikushige Y, Tokuyama T, et al. Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment. Blood. 2013;121(8):1316\u201325. https:\/\/doi.org\/10.1182\/blood-2012-06-440354.","journal-title":"Blood"},{"issue":"1","key":"292_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/imm.12290","volume":"143","author":"LS Kwong","year":"2014","unstructured":"Kwong LS, Brown MH, Barclay AN, Hatherley D. Signal-regulatory protein \u03b1 from the NOD mouse binds human CD47 with an exceptionally high affinity- implications for engraftment of human cells. Immunology. 2014;143(1):61\u20137. https:\/\/doi.org\/10.1111\/imm.12290.","journal-title":"Immunology"},{"issue":"9","key":"292_CR29","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","volume":"100","author":"M Ito","year":"2002","unstructured":"Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, et al. NOD\/SCID\/gcnull mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002;100(9):3175\u201382. https:\/\/doi.org\/10.1182\/blood-2001-12-0207.","journal-title":"Blood"},{"issue":"9","key":"292_CR30","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","volume":"100","author":"M Ito","year":"2002","unstructured":"Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, et al. NOD\/SCID\/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002;100(9):3175\u201382. https:\/\/doi.org\/10.1182\/blood-2001-12-0207.","journal-title":"Blood"},{"issue":"3","key":"292_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1046\/j.1365-2613.1997.230356.x","volume":"78","author":"M Ikebe","year":"1997","unstructured":"Ikebe M, Miyakawa K, Takahashi K, Ohbo K, Nakamura M, Sugamura K, et al. Lymphohaematopoietic abnormalities and systemic lymphoproliferative disorder in interleukin-2 receptor g chain-deficient mice. Int J Exp Pathol. 1997;78(3):133\u201348. https:\/\/doi.org\/10.1046\/j.1365-2613.1997.230356.x.","journal-title":"Int J Exp Pathol"},{"issue":"1","key":"292_CR32","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4049\/jimmunol.154.1.180","volume":"154","author":"LD Shultz","year":"1995","unstructured":"Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, et al. Multiphle defects in innate and adaptive immunologic function in NOD\/LtSz-scid mice. J Immunol. 1995;154(1):180\u201391.","journal-title":"J Immunol"},{"issue":"10","key":"292_CR33","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","volume":"174","author":"LD Shultz","year":"2005","unstructured":"Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S, et al. Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol. 2005;174(10):6477\u201389. https:\/\/doi.org\/10.4049\/jimmunol.174.10.6477.","journal-title":"J Immunol"},{"issue":"10","key":"292_CR34","doi-asserted-by":"publisher","first-page":"7009","DOI":"10.4049\/jimmunol.180.10.7009","volume":"180","author":"MR Simpson-Abelson","year":"2008","unstructured":"Simpson-Abelson MR, Sonnenberg GF, Takita H, Yokota SJ, Conway TF Jr, Kelleher RJ Jr., et al. Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma (null) mice. J Immunol. 2008;180(10):7009\u201318. https:\/\/doi.org\/10.4049\/jimmunol.180.10.7009.","journal-title":"J Immunol"},{"key":"292_CR35","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2147\/CMAR.S71185","volume":"6","author":"N Kanaji","year":"2014","unstructured":"Kanaji N, Tadokoro A, Susaki K, Yokokura S, Ohmichi K, Haba R, et al. Higher susceptibility of NOD\/LtSz-scid Il2rg (-\/-) NSG mice to xenotransplanted lung cancer cell lines. Cancer Manag Res. 2014;6:431\u20136. https:\/\/doi.org\/10.2147\/CMAR.S71185.","journal-title":"Cancer Manag Res"},{"issue":"9","key":"292_CR36","doi-asserted-by":"publisher","first-page":"e0163521","DOI":"10.1371\/journal.pone.0163521","volume":"11","author":"M Puchalapalli","year":"2016","unstructured":"Puchalapalli M, Zeng X, Mu L, Anderson A, Hix Glickman L, Zhang M, et al. NSG Mice Provide a Better Spontaneous Model of Breast Cancer Metastasis than Athymic (Nude) Mice. PLoS ONE. 2016;11(9):e0163521. https:\/\/doi.org\/10.1371\/journal.pone.0163521.","journal-title":"PLoS ONE"},{"key":"292_CR37","doi-asserted-by":"publisher","first-page":"28093","DOI":"10.1038\/srep28093","volume":"6","author":"S Majji","year":"2016","unstructured":"Majji S, Wijayalath W, Shashikumar S, Pow-Sang L, Villasante E, Brumeanu TD, et al. Differential effect of HLA class-I versus class-II transgenes on human T and B cell reconstitution and function in NRG mice. Sci Rep. 2016;6:28093. https:\/\/doi.org\/10.1038\/srep28093.","journal-title":"Sci Rep"},{"key":"292_CR38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.exphem.2018.08.004","volume":"67","author":"A Barve","year":"2018","unstructured":"Barve A, Casson L, Krem M, Wunderlich M, Mulloy JC, Beverly LJ. Comparative utility of NRG and NRGS mice for the study of normal hematopoiesis, leukemogenesis, and therapeutic response. Exp Hematol. 2018;67:18\u201331. https:\/\/doi.org\/10.1016\/j.exphem.2018.08.004.","journal-title":"Exp Hematol"},{"issue":"11","key":"292_CR39","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.3390\/cancers15112989","volume":"15","author":"A Chen","year":"2023","unstructured":"Chen A, Neuwirth I, Herndler-Brandstetter D. Modeling the tumor microenvironment and cancer immunotherapy in next-generation humanized mice. Cancers (Basel). 2023;15(11):2989. https:\/\/doi.org\/10.3390\/cancers15112989.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"292_CR40","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1101\/pdb.top073585","volume":"2014","author":"LD Shultz","year":"2014","unstructured":"Shultz LD, Goodwin N, Ishikawa F, Hosur V, Lyons BL, Greiner DL. Human cancer growth and therapy in immunodeficient mouse models. Cold Spring Harb Protoc. 2014;2014(7):694\u2013708. https:\/\/doi.org\/10.1101\/pdb.top073585.","journal-title":"Cold Spring Harb Protoc"},{"key":"292_CR41","doi-asserted-by":"publisher","first-page":"15211","DOI":"10.1002\/0471142735.im1521s81","volume":"Chap 15","author":"T Pearson","year":"2008","unstructured":"Pearson T, Greiner DL, Shultz LD. Creation of humanized mice to study human immunity. Curr Protoc Immunol. 2008;Chap 15:15211\u2013152121. https:\/\/doi.org\/10.1002\/0471142735.im1521s81.","journal-title":"Curr Protoc Immunol"},{"issue":"2","key":"292_CR42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s40259-013-0071-0","volume":"28","author":"G Proetzel","year":"2014","unstructured":"Proetzel G, Wiles MV, Roopenian DC. Genetically engineered humanized mouse models for preclinical antibody studies. Biodrugs. 2014;28(2):171\u201380. https:\/\/doi.org\/10.1007\/s40259-013-0071-0.","journal-title":"Biodrugs"},{"issue":"3","key":"292_CR43","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1538\/expanim.23-0025","volume":"72","author":"Y Ka","year":"2023","unstructured":"Ka Y, Ito R, Nozu R, Tomiyama K, Ueno M, Ogura T, et al. Establishment of a human microbiome- and immune system-reconstituted dual-humanized mouse model. Exp Anim. 2023;72(3):402\u201312. https:\/\/doi.org\/10.1538\/expanim.23-0025.","journal-title":"Exp Anim"},{"issue":"8","key":"292_CR44","doi-asserted-by":"publisher","first-page":"e852","DOI":"10.1002\/cpz1.852","volume":"3","author":"R Kumari","year":"2023","unstructured":"Kumari R, Feuer G, Bourr\u00e9 L. Humanized mouse models for immuno-oncology drug discovery. Curr Protoc. 2023;3(8):e852. https:\/\/doi.org\/10.1002\/cpz1.852.","journal-title":"Curr Protoc"},{"key":"292_CR45","doi-asserted-by":"publisher","first-page":"673199","DOI":"10.3389\/fonc.2021.673199","volume":"11","author":"W Guo","year":"2021","unstructured":"Guo W, Zhang C, Qiao T, Zhao J, Shi C. Strategies for the construction of mouse models with humanized immune system and evaluation of tumor immune checkpoint inhibitor therapy. Front Oncol. 2021;11:673199. https:\/\/doi.org\/10.3389\/fonc.2021.673199.","journal-title":"Front Oncol"},{"issue":"3","key":"292_CR46","doi-asserted-by":"publisher","first-page":"100781","DOI":"10.1016\/j.jtocrr.2024.100781","volume":"6","author":"CK Park","year":"2024","unstructured":"Park CK, Khalil M, Pharm NA, Wong S, Ly D, Sacher A, et al. Humanized mouse models for immuno-oncology research: a review and implications in lung cancer research. JTO Clin Res Rep. 2024;6(3):100781. https:\/\/doi.org\/10.1016\/j.jtocrr.2024.100781.","journal-title":"JTO Clin Res Rep"},{"issue":"11","key":"292_CR47","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.3390\/cancers15112989","volume":"15","author":"A Chen","year":"2023","unstructured":"Chen A, Neuwirth I, Herndler-Brandstetter D. Modeling the tumor microenvionment and cancer immunotherapy in next-generation humanized mice. Cancers. 2023;15(11):2989. https:\/\/doi.org\/10.3390\/cancers15112989.","journal-title":"Cancers"},{"issue":"1","key":"292_CR48","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1002\/cpph.77","volume":"89","author":"B Verma","year":"2020","unstructured":"Verma B, Wesa A. Establishment of humanized mice from peripheral blood mononuclear cells or cord blood CD34\u2009+\u2009hematopoietic stem cells for immune-oncology studies evaluating new therapeutic agents. Curr Protoc Pharmacol. 2020;89(1):e77. https:\/\/doi.org\/10.1002\/cpph.77.","journal-title":"Curr Protoc Pharmacol"},{"key":"292_CR49","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41571-022-00721-2","volume":"20","author":"J Chuprin","year":"2023","unstructured":"Chuprin J, Buettner H, Seedhom MO, Greiner DL, Keck JG, Ishikawa F, et al. Hummanized mouse models for immuno-oncology research. Nat Rev Clin Oncol. 2023;20:192\u2013206. https:\/\/doi.org\/10.1038\/s41571-022-00721-2.","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"292_CR50","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.3390\/biomedicines12092152","volume":"19","author":"X Huang","year":"2024","unstructured":"Huang X, Wang Q, Nan Y, Zhang X, Xu K, Ju D, et al. Targeting CD47 and angiogenesis demonstrate effective anti-tumor effect in bladder cancer. Biomedicines. 2024;19(9):2152. https:\/\/doi.org\/10.3390\/biomedicines12092152.","journal-title":"Biomedicines"},{"issue":"2","key":"292_CR51","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1182\/blood-2010-02-271841","volume":"116","author":"SP McDermott","year":"2010","unstructured":"McDermott SP, Eppert K, Lechman ER, Doedens M, Dick JE. Comparison of human cord blood engraftment between immunocompromised mouse strains. Blood. 2010;116(2):193\u2013200. https:\/\/doi.org\/10.1182\/blood-2010-02-271841.","journal-title":"Blood"},{"issue":"6","key":"292_CR52","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/ijc.2910240605","volume":"24","author":"FE Sharkey","year":"1979","unstructured":"Sharkey FE, Fogh J. Metastasis of human tumors in athymic nude mice. Int J Cancer. 1979;24(6):733\u201338. https:\/\/doi.org\/10.1002\/ijc.2910240605.","journal-title":"Int J Cancer"},{"issue":"10","key":"292_CR53","first-page":"3186","volume":"38","author":"AP Kyriazis","year":"1978","unstructured":"Kyriazis AP, DiPersio L, Michael GJ, Pesce AJ, Stinnett JD. Growth patterns and metastatic behavior of human tumors growing in athymic mice. Cancer Res. 1978;38(10):3186\u201390.","journal-title":"Cancer Res"},{"issue":"3","key":"292_CR54","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1269\/jrr.31.288","volume":"31","author":"T Nomura","year":"1990","unstructured":"Nomura T, Takahama Y, Hongyo T, Inohara H, Takatera H, Fukushima H, et al. SCID (severe combined immunodeficiency) mice as a new system to investigate metastasis of human tumors. J Radiat Res. 1990;31(3):288\u201392. https:\/\/doi.org\/10.1269\/jrr.31.288.","journal-title":"J Radiat Res"},{"issue":"8","key":"292_CR55","doi-asserted-by":"publisher","first-page":"e71270","DOI":"10.1371\/journal.pone.00271270","volume":"8","author":"CC Milsom","year":"2013","unstructured":"Milsom CC, Lee CR, Hackl C, Man S, Kerbel RS. Differential post-surgical metastasis and survival in SCID, NOD-SCID and NOD-SCID-IL-2R\u03b3null mice with parental and subline variants of human breast cancer: implications for host defense mechanisms regulating metastasis. PLoS ONE. 2013;8(8):e71270. https:\/\/doi.org\/10.1371\/journal.pone.00271270.","journal-title":"PLoS ONE"},{"key":"292_CR56","doi-asserted-by":"publisher","first-page":"6695","DOI":"10.2147\/CMAR.S181272","volume":"10","author":"J Wu","year":"2018","unstructured":"Wu J, Zhang J, Jiang M, Zhang T, Wang Y, Wang Z, et al. Comparison between NOD\/SCID mice and BALB\/c mice for patient-derived tumor xenografts model of non-small-cell lung cancer. Cancer Manag Res. 2018;10:6695\u2013703. https:\/\/doi.org\/10.2147\/CMAR.S181272.","journal-title":"Cancer Manag Res"},{"key":"292_CR57","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-3-540-75647-7_11","volume":"324","author":"M Nakamura","year":"2008","unstructured":"Nakamura M, Suemizu H. Novel metastasis models of human cancer in NOG mice. Curr Top Microbiol Immunol. 2008;324:167\u201377. https:\/\/doi.org\/10.1007\/978-3-540-75647-7_11.","journal-title":"Curr Top Microbiol Immunol"},{"key":"292_CR58","first-page":"19","volume":"26","author":"H Sartelet","year":"2012","unstructured":"Sartelet H, Durrieu L, Fontaine F, Nyalendo C, Haddad E. Description of a new xenograft model of metastatic neuroblastoma using NOD\/SCID\/Il2rg null (NSG) mice. Vivo. 2012;26:19\u201329.","journal-title":"Vivo"},{"issue":"1","key":"292_CR59","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1021\/acs.molpharmaceut.4c01071","volume":"22","author":"M Kondo","year":"2025","unstructured":"Kondo M, Cai Z, Chan C, Brown MK, Reilly RM. Preclinical Comparison of [111In]In- and [225Ac]Ac-DOTA-Trastuzumab IgG, F(ab\u2019)2 and Fab for Theranostic SPECT\/CT Imaging and \u03b1-Particle Radioimmunotherapy of HER2-Positive Human Breast Cancer. Mol Pharm. 2025;22(1):474\u201387. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.4c01071.","journal-title":"Mol Pharm"},{"issue":"1","key":"292_CR60","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/j.ijrobp.2012.02.030","volume":"81","author":"J Jung","year":"2012","unstructured":"Jung J, Park SJ, Chung HK, Kang HW, Lee SW, Seo MH, et al. Polymeric nanoparticles containing taxanes enhance chemoradiotherpaeutic efficacy in non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2012;81(1):e77\u201383. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.02.030.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"292_CR61","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s43188-022-00139-z","volume":"38","author":"S Lee","year":"2022","unstructured":"Lee S, Lee GS, Moon JH, Jung J. Policosanol suppresses tumor progression in a gastric cancer xenograft model. Toxicol Res. 2022;38:567\u201375. https:\/\/doi.org\/10.1007\/s43188-022-00139-z.","journal-title":"Toxicol Res"},{"issue":"4","key":"292_CR62","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4174\/astr.2017.93.4.173.Epub2017Sep28","volume":"93","author":"J Jung","year":"2017","unstructured":"Jung J, Kim J, Lim HK, Kim KM, Lee YS, Park JS, et al. Establishing a colorectal cancer liver metastasis patient-derived tumor xenograft model for the evaluation of personalized chemotherapy. Ann Surg Treat Res. 2017;93(4):173\u201380. https:\/\/doi.org\/10.4174\/astr.2017.93.4.173.Epub2017Sep28.","journal-title":"Ann Surg Treat Res"},{"key":"292_CR63","doi-asserted-by":"publisher","first-page":"115613","DOI":"10.1016\/j.biopha.2023.115613","volume":"167","author":"N Kim","year":"2023","unstructured":"Kim N, Kwon J, Shin US, Jung J. Fisetin induces the upregulation of AKAP12 mRNA and anti-angiogenesis in a patient-derived organoid xenograft model. Biomed Pharmacother. 2023;167:115613. https:\/\/doi.org\/10.1016\/j.biopha.2023.115613.","journal-title":"Biomed Pharmacother"},{"key":"292_CR64","doi-asserted-by":"publisher","first-page":"560605","DOI":"10.3389\/fendo.2020.560605","volume":"11","author":"K Kim","year":"2020","unstructured":"Kim K, Jung J. Upregulation of G protein-coupled estrogen receptor by chrysin-nanoparticles inhibits tumor proliferation and metastasis in triple negative breast cancer xenograft model. Front Endocrinol. 2020;11:560605. https:\/\/doi.org\/10.3389\/fendo.2020.560605.","journal-title":"Front Endocrinol"},{"issue":"5","key":"292_CR65","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1593\/neo.07205","volume":"9","author":"D Liu","year":"2007","unstructured":"Liu D, Hornsby PJ. Fibroblast stimulation of blood vessel development and cancer cell invasion in a subrenal capsule xenograft model: stress-induced premature senescence does not increase effect1. Neoplasia. 2007;9(5):418\u201326. https:\/\/doi.org\/10.1593\/neo.07205.","journal-title":"Neoplasia"},{"issue":"1","key":"292_CR66","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/nu14010134","volume":"14","author":"HJ Kwon","year":"2022","unstructured":"Kwon HJ, Lee S, Lee HH, Cho H, Jung J. Korean red ginseng enhances immunotherapeutic effects of NK cells via eosinophils in metastatic liver cancer model. Nutrients. 2022;14(1):134. https:\/\/doi.org\/10.3390\/nu14010134.","journal-title":"Nutrients"}],"container-title":["Laboratory Animal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42826-026-00292-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42826-026-00292-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42826-026-00292-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:42:59Z","timestamp":1787640179000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42826-026-00292-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["292"],"URL":"https:\/\/doi.org\/10.1186\/s42826-026-00292-8","relation":{},"ISSN":["2233-7660"],"issn-type":[{"value":"2233-7660","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"30"}}